DISINFO: Registration of Sputnik V in the EU is voluntary delayed for political or economic reasons
SUMMARY
The European Union voluntarily delay the registration of the Russian vaccine Sputnik V. The experts and specialists of the European Medicines Agency [EMA] are not to blame but it is known for sure that this delay is due to signals given to them by high-ranking people in the European Union.
Are there only political reasons for this, or is there also an economic factor? It is unknown.
The citizens of European countries themselves and their police and justice forces should investigate to understand the goal of such a manoeuvre.
RESPONSE
Recurrent disinformation message around the Sputnik V and the European Medicines Agency (EMA).
There is no evidence of EU bias against the Russian vaccine or that EU officials are blocking its certification. EMA Executive Director Emer Cooke said she hoped the Sputnik V vaccine would be approved. For that EMA is conducting a rolling review including a visit to Russian facilities.
The EMA has certified four vaccines so far. The rolling review of Sputnik V was launched on 4 March 2021. Pro-Kremlin media often quote an article in The Lancet magazine, which showed 91.6 per cent effectiveness of Sputnik V without considerable side effects. However, there have been some doubts as to its efficacy, especially where the trial procedures are concerned (see here and here.) Recently, in the Lancet article published 12 May 2021 critical questions about the Sputnik V data for phase III clinical trial were raised.
There is no Russophobia in the way the EMA is dealing with the Sputnik V vaccine.
The EMA applies the same regulatory approach to all vaccine applications to check them for safety and efficacy.
Read also related stories: EU prepares new smear campaign against Russia, accuses it of anti-vax activities, Sputnik V submitted its application to EMA on 21 January , The head of the EMA stated that she would seek to ban Russian vaccine , EMA's delay in approving Sputnik V is political